Skip to main content

Table 1 Percentage of cell cycle phases was measured by flow cytometry after treatment with PINO

From: Phytoestrogen (+)-pinoresinol exerts antitumor activity in breast cancer cells with different oestrogen receptor statuses

MDA-MB-231 MCF7 MCF10A
  SubG0/G1 G0/G1 S G2/M SubG0/G1 G0/G1 S G2/M SubG0/G1 G0/G1 S G2/M
Control 1.72 ± 0.3 60.67 ± 4.8 17.01 ± 2.33 20.59 ± 2.46 0.69 ± 0.11 61.57 ± 0.19 16.72 ± 0.86 21.00 ± 0.74 1.23 ± 0.17 56.45 ± 0.2 20.96 ± 1.29 17.91 ± 1.08
0.001 μM 2.57 ± 0.7 60.87 ± 3.37 16.75 ± 1.68 20.23 ± 2.56 0.54 ± 0.03 62.71 ± 0.23 16.70 ± 0.43 20.60 ± 0.73 1.86 ± 0.7 55.32 ± 1.43 22.44 ± 0.34 16.77 ± 1.02
0.01 μM 1.80 ± 0.21 59.16 ± 4.53 17.55 ± 2.68 20.71 ± 2.01 0.62 ± 0.14 61.64 ± 1 16.72 ± 0.25 21.58 ± 0.93 1.67 ± 0.42 54.12 ± 2.3 21.79 ± 0.62 17.36 ± 1.47
0.1 μM 1.32 ± 0.24 59.33 ± 4.15 18.92 ± 1.68 20.35 ± 2.38 0.49 ± 0.02 60.71 ± 0.51 18.41 ± 0.5 20.61 ± 0.64 1.45 ± 0.22 54.84 ± 1.19 20.47 ± 0.53 19.09 ± 1.1
1 μM 1.62 ± 0.29 60.63 ± 4.93 18.56 ± 2.45 19.37 ± 2.48 0.49 ± 0.03 62.99 ± 1.28 16.99 ± 0.62 20.12 ± 1.06 1.85 ± 0.25 54.72 ± 0.65 21.23 ± 0.8 17.58 ± 1.16
10 μM 1.76 ± 0.3 64.85 ± 4.74 17.6 ± 2.38 15.52 ± 2.21 0.57 ± 0.03 61.73 ± 0.65 18.08 ± 0.41 19.62 ± 0.73 1.66 ± 0.12 53.93 ± 1.54 20.23 ± 1.1 19.6 ± 0.84
100 μM 2.29 ± 0.44 73.39 ± 1.69a 8.34 ± 0.94a 16.06 ± 1.8 0.81 ± 0.19 63.92 ± 1.13 11.96 ± 0.68a 23.38 ± 0.85 1.26 ± 0.23 76.1 ± 2.01a 9.92 ± 1.02a 9.45 ± 2.1a
  1. Values represent the percentage of the average ± SEM of three independent experiments. a indicates statistically significant differences with respect to control (p < 0.05)